Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pulmonary Artery Catheter Use Down Sharply, Research Shows

This article was originally published in The Gray Sheet

Executive Summary

Pulmonary artery catheterization in the United States - once common for critical care - has dropped so dramatically that it should either be discontinued entirely or performed only by physicians highly skilled in the procedure, according to articles in the July 25 Journal of the American Medical Association.

You may also be interested in...



Tufts Report Finds No Benefit From Routine Pulmonary Artery Catheterization

Pulmonary artery catheterization for monitoring cardiac function was once common in the intensive care units, but a new technology assessment requested by the government shows there is little evidence that the procedure is effective in critical care settings

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel